IL98405A0 - Pharmaceutical compositions containing enzyme inhibiting agents - Google Patents

Pharmaceutical compositions containing enzyme inhibiting agents

Info

Publication number
IL98405A0
IL98405A0 IL98405A IL9840591A IL98405A0 IL 98405 A0 IL98405 A0 IL 98405A0 IL 98405 A IL98405 A IL 98405A IL 9840591 A IL9840591 A IL 9840591A IL 98405 A0 IL98405 A0 IL 98405A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
inhibiting agents
containing enzyme
enzyme inhibiting
Prior art date
Application number
IL98405A
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of IL98405A0 publication Critical patent/IL98405A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
IL98405A 1990-06-11 1991-06-06 Pharmaceutical compositions containing enzyme inhibiting agents IL98405A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53579490A 1990-06-11 1990-06-11

Publications (1)

Publication Number Publication Date
IL98405A0 true IL98405A0 (en) 1992-07-15

Family

ID=24135791

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98405A IL98405A0 (en) 1990-06-11 1991-06-06 Pharmaceutical compositions containing enzyme inhibiting agents

Country Status (7)

Country Link
AU (1) AU8185491A (en)
CS (1) CS176291A3 (en)
IE (1) IE911971A1 (en)
IL (1) IL98405A0 (en)
PT (1) PT97937A (en)
WO (1) WO1991019418A1 (en)
ZA (1) ZA914435B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US5767373A (en) * 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US6084155A (en) 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
KR100493500B1 (en) * 1996-02-28 2006-09-20 신젠타 파티서페이션즈 아게 Dna molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
CN103694243B (en) * 2013-12-20 2015-09-09 中国农业大学 2-substituted pyridinyl-1,2,4-triazolo [1,2-a] pyridazine compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190371B (en) * 1980-12-18 1986-08-28 The Wellcome Foundation Ltd,Gb Process for producing ether-type compounds and pharmaceutical compositions containing them as active agents
CA1192545A (en) * 1982-02-16 1985-08-27 Glaxo Group Limited Heterocyclic derivatives as histamine h.sub.2- antagonists
US5025029A (en) * 1986-10-10 1991-06-18 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin
US4820722A (en) * 1987-08-14 1989-04-11 Eli Lilly And Company Disubstituted tetrazoles and their use as leukotriene antagonists
US4847276A (en) * 1988-09-06 1989-07-11 Merrell Dow Pharmaceuticals Inc. Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione

Also Published As

Publication number Publication date
AU8185491A (en) 1992-01-07
ZA914435B (en) 1992-03-25
WO1991019418A1 (en) 1991-12-26
IE911971A1 (en) 1991-12-18
PT97937A (en) 1992-04-30
CS176291A3 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
GB9224855D0 (en) Pharmaceutical compositions
GB9308014D0 (en) Pharmaceutical compositions
HUT66864A (en) Pharmaceutical compositions
GB9115893D0 (en) Pharmaceutical compositions
IL98749A0 (en) Pharmaceutical compositions containing penciclovir
IL98405A0 (en) Pharmaceutical compositions containing enzyme inhibiting agents
GB9111314D0 (en) Pharmaceutical compositions
GB9209874D0 (en) Pharmaceutical compositions
GB9122083D0 (en) Pharmaceutical compositions
GB9026080D0 (en) Pharmaceutical compositions
GB9003185D0 (en) Pharmaceutical compositions
GB9226377D0 (en) Pharmaceutical compositions
ZA917596B (en) Pharmaceutical compositions
GB9115156D0 (en) Pharmaceutical compositions
GB9211276D0 (en) Pharmaceutical compositions
GB9115169D0 (en) Pharmaceutical compositions
GB9026882D0 (en) Pharmaceutical compositions
GB9026391D0 (en) Pharmaceutical compositions
GB9017202D0 (en) Pharmaceutical compositions
GB9027605D0 (en) Pharmaceutical compositions
ZW10690A1 (en) Pharmaceutical compositions
GB9023655D0 (en) Pharmaceutical compositions
GB9016660D0 (en) Pharmaceutical compositions
GB9014736D0 (en) Pharmaceutical compositions